Driving Innovation in Drug Discovery Using Generative AI with Bayer
Industries Blog
Bayer partnered with AWS to leverage generative AI in accelerating drug discovery, focusing on innovative solutions to reduce costs and time in predicting chemical reaction conditions.
- AWS PACE team developed a solution in a 6-week engagement
- Created a chatbot that answers scientific queries in natural language
- Prototype model successfully predicts chemical reaction conditions
- Goal is to narrow infinite possibilities to promising drug discovery outcomes
- Demonstrates generative AI's potential to transform pharmaceutical research
The collaboration highlights how generative AI can significantly streamline and enhance the drug discovery process by providing faster, more efficient research tools.
The AWS News Feed is currently looking for gold sponsors. If you want to support the AWS community and reach a large audience of AWS professionals, consider sponsoring the AWS News Feed.
Related articles
Dec 11
2024
2024
Quartz Atlas AI for Drug Discovery
Dec 12
2025
2025
How Bayer transforms Pharma R&D with a cloud-based data science ecosystem using Amazon SageMaker
Jul 25
2024
2024
Guided multi-objective generative AI for drug design
Jan 10
2025
2025
Revolutionizing Real-World Evidence: How Generative AI Can Simplify Data Exploration
The AWS News Feed is currently looking for silver sponsors. If you want to support the AWS community and reach a large audience of AWS professionals, consider sponsoring the AWS News Feed.